AHA infective endocarditis 2015 khotailieu y hoc
➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạmNội dung chi tiết: AHA infective endocarditis 2015 khotailieu y hoc
AHA infective endocarditis 2015 khotailieu y hoc
AHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hoc Healthcare Professionals From the American Heart AssociationEndorsed by the Infectious Diseases Society of AmericaLarry M. Baddour. MD. FAHA. Chair: Walter R. Wilson. MD: Arnold s. Bayer. MD;Vance G. Fowler. Jr. MD. MHS: Imad M. Tleyjeh. MD. MSc;Michael J. Rybak. PharniD. MPH: Bruno Barsic. MD. PhD AHA infective endocarditis 2015 khotailieu y hoc: Peter B. Lockhart. DDS:Michael H. Gewitz. MD. FAHA: Matthew E. Levison. MD: Ann F. Bolger. MD. FAHA:James M. Steckelberg, MD; Robert s. Baltimore. MAHA infective endocarditis 2015 khotailieu y hoc
D: Anne M. Fink. PhD. RN:Patrick O'Gara. MD. FAHA: Kathryn A. Taubert. PhD. FAHA; on behalf of the American Heart Association Committee on Rheumatic FAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocar Surgery and Anesthesia, and Stroke CouncilBackground— Infective endocarditis is a potentially lethal disease that has undergone major changes in both host and pathogen. The epidemiology of infective endocarditis has become more complex with today's myriad healthcare-associated factors that predis AHA infective endocarditis 2015 khotailieu y hocpose to infection. Moreover, changes in pathogen prevalence, in particular a more common staphylococcal origin, have affected outcomes, which have notAHA infective endocarditis 2015 khotailieu y hoc
improved despite medical and surgical advances.Methods and Results—This statement updates the 2005 iteration, both of which were developed by the AmeAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocof the Young. Il includes an evidence-based system for diagnostic and treatment recommendations used by the American College of Cardiology and the American Heart Association for treatment recommendations.Conclusions—Infective endocarditis is a complex disease, and patients with this disease generall AHA infective endocarditis 2015 khotailieu y hocy require management by a team of physicians and allied health providers with a variety of areas of expertise. The recommendations provided in this doAHA infective endocarditis 2015 khotailieu y hoc
cument arc intended to assist in the management of (his uncommon but potentially deadly infection. The clinical variability anti complexity in infectiAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocion. 2015;132:1435-1486. DOI: 10.1161/CI R.0000000000000296.)Key Words: AHA Scientific Statements ■ anti-infective agents ■ echocardiography ■ endocarditis ■ infectionTnfcctivc endocarditis (IE) is an uncommon infectious dis-JLease with an annual incidence ranging from 3 to 7 per 100000 person-years AHA infective endocarditis 2015 khotailieu y hoc in the most contemporary populationsurveys.1-’ Although relatively rare. IE continues to be characterized by increased morbidity and mortality and isAHA infective endocarditis 2015 khotailieu y hoc
now the third or fourth most common life-threatening infectionThe American Heart Association makes every effort to awMd any actual or potential conflAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocnel. Specifically, all members of the w riting group arc required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement was approved by tile American Heart Association Science Advisory and Co AHA infective endocarditis 2015 khotailieu y hocordinating Committee on May 12. 2015. and the American Heart Association Executive Committee on June 12.2015. A copy of the document is available at hAHA infective endocarditis 2015 khotailieu y hoc
ttp7/my amcrkanheart.org/siatements by selecting either the “By Topic" link or the "By Publication Date" link. To purchase additional reprints, call 8AHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocson WR. Bayer AS. Fowler VG Jr. Tleyjch IM. Rybak MJ. Bank B. Lockhart PB. Gewitz MH. Levison ME Bolger AF. Steckelberg JM. Baltimore RS. Fink AM. O’Gara p. Taubert KA. on behalf of the American Heart Association Committee on Rheumatic Fever. Endocarditis, and Kawasaki Disease of the Council on Card AHA infective endocarditis 2015 khotailieu y hociovascular Disease m the Yeung. Council on Clinical Cardiology. Council on Cardiovascular Surgery and Anesthesia, and Stroke Council Infective endixarAHA infective endocarditis 2015 khotailieu y hoc
ditis in adults: diagnosis, antimicrobial therapy, and management of complications. a scientific statement for lieallhcare professionals from the AmerAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocrations. For more on AHA statements and guidelines development, visit http://my.ameneanlieari.org/statemenis and select the "Policies and Development" link.Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express AHA infective endocarditis 2015 khotailieu y hocpermission of the American Heart Association Instructions for obtaining permission are located at hitp://www.heart org/HEARTORG/Gcneral/Copyright-PermAHA infective endocarditis 2015 khotailieu y hoc
ission-Gmdelines_UCM_3l)(M04_Article.jsp. A link to the "Copyright Permissions Request Form" appears on the light Mde of Ute page.(Circulation. 2015:1AHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hoc116I/Í ’IR.WKMMKMMMMMI0U296Downloaded from http://circ.ahajoiMlB.org’ by guest on October 13. 20151436 Circulation October 13,2015syndrome, after sepsis, pneumonia, and intra-abdominal abscess. Globally, in 2010. IE was associated with 1.58 million disability-adjusted life-years or years of healthy AHA infective endocarditis 2015 khotailieu y hoclife lost as a result of death and nonfatal illness or impairment.4Epidemiological surveys from France and the International Collaboration on EndocardAHA infective endocarditis 2015 khotailieu y hoc
itis have confirmed that the epidemiological profile of IE has changed substantially. Although the overall IE incidence has remained stable,'"•’■•the AHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocrld. The emergence of s aureus IE is due in part to the increasing importance of healthcare contact as a leading risk associated with infection. Characteristics of IE patients have also shifted toward an increased mean patient age. a higher proportion of prosthetic valves and other cardiac devices, AHA infective endocarditis 2015 khotailieu y hocand a decreasing proportion of rheumatic heart disease. Moreover, the proportion of IE patients undergoing surgery has increased over time to reach «5AHA infective endocarditis 2015 khotailieu y hoc
0%.■•"UlIn addition to these temporal epidemiological changes, major new findings from multiple diagnostic, prognostic, and therapeutic studies have bAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocd in 2OO5.12 For example, the rapid detection of pathogens from valve tissue from patients undergoing surgery for IE by polymerase chain reaction (PCR) has been validated. Moreover, diagnostic innovations have emerged through new imaging techniques such as 3-dimensional (3D) echocardiography, "Itead AHA infective endocarditis 2015 khotailieu y hoc-to-toe" multislice computed tomography (CT), and cardiac magnetic resonance imaging (MRI). Furthermore, the role of cerebral MR1 and magnetic resonanAHA infective endocarditis 2015 khotailieu y hoc
ce angiography in the diagnosis and management of IE has been better defined in several studies. In addition. several risk stratification models for qAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hoclly, daptoinycin has been evaluated in the treatment of s aureus bacteremia and IE in a randomized, controlled trial.13 Several rigorously conducted observational studies'and a randomized, controlled trial17 have examined the impact and timing of valve surgery in IE management. In addition, updated AHA infective endocarditis 2015 khotailieu y hocinternational management guidelines have been published.'*■’*The present AHA IE Writing Committee conducted comprehensive and focused reviews of the lAHA infective endocarditis 2015 khotailieu y hoc
iterature published between January 20()5 and October 2013 to update the previous version of the guidelines. Literature searches of the PubMed/ MEDLINAHA Scientific statementInfective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of ComplicationsA Scientific Statement for AHA infective endocarditis 2015 khotailieu y hocs, infective endocarditis. infectious endocarditis, intracardiac, valvular, mural, infection. diagnosis, bacteremia, case definition, epidemiology, risks, demographics, injection drtig use. echocardiography, microbiology, culture-negative, therapy, antibiotic, antifungal, antimicrobial, antimicrobia AHA infective endocarditis 2015 khotailieu y hocl resistance, adverse drag effects, drug monitoring, outcome, meta-analysis. complications, abscess, heart failure, embolic events, stroke, conductionAHA infective endocarditis 2015 khotailieu y hoc
abnormalities, survival, pathogens, organisms, treatment, surgery. indications, valve replacement, valve repair, ambulatory care trials, and preventiGọi ngay
Chat zalo
Facebook